ConductScience.org, home

Trial · NCT07904377

ACORYS AI4AF PILOT STUDY

NCT07904377, Recruiting, Mayo Clinic

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. ACORYS AI4AF PILOT STUDY. Trials, record NCT07904377. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07904377

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
ACORYS AI4AF PILOT STUDY
NCT number
NCT07904377
Status
Recruiting
Enrollment
200 participants, estimated
Lead sponsor
Mayo Clinic
Conditions
Atrial Arrhythmia
Interventions
Acorys Mapping System
First posted
2026-10-29
Last updated
2026-10-29

Source ClinicalTrials.gov

Registered outcomes15

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryPercentage of accurate post ablation outcome predictions Percentage of Accurate Post-Ablation Outcome Predictions12 Months
The ACORYS-AI4AF model will use non-invasive mapping data collected during standard clinical procedures to predict post-ablation outcomes. Accuracy will be reported as the percentage of predictions that correctly correspond with the observed post-ablation outcome.
PrimaryNumber of Patients to remain arrhythmia-free after pulmonary vein isolation (PVI) alone12 Months
Freedom from atrial fibrillation, atrial tachycardia, or atrial flutter lasting longer than 30 seconds, with or without symptoms, after a single ablation procedure (excluding episodes within the first 6 weeks post-procedure). This will be Measured through any of the following per standard of care procedures: 12-lead ECG, ambulatory rhythm monitoring devices, Consumer-facing wearable ECG devices (e.g., AliveCor KardiaMobile 6L, Apple Watch, etc), and Cardiac implanted electronic devices (implanted loop recorders, pacemakers, defibrillators).
PrimaryNumber of Patients not remaining arrhythmia-free after pulmonary vein isolation (PVI) and requiring additional atrial substrate ablation.12 Months
Freedom from atrial fibrillation, atrial tachycardia, or atrial flutter lasting longer than 30 seconds, with or without symptoms, after a single ablation procedure (excluding episodes within the first 6 weeks post-procedure). This will be Measured by the number of patients to undergo a second atrial substrate ablation post procedure.
SecondaryPercentage of patients with identified critical atrial regions contributing to arrhythmia maintenance for whom post-ablation outcomes were accurately predicted12 Months
Percentage of patients with identified critical atrial regions contributing to arrhythmia maintenance whose observed post-ablation outcome matched the outcome predicted based on the identified regions. Prediction accuracy is calculated as the proportion of correct predictions among all evaluated patients.
SecondaryAccuracy of Imageless Electrocardiographic Imaging (ECGI) in Identifying Arrhythmogenic Substrates12 Months
The accuracy of Imageless Electrocardiographic Imaging (ECGI) in identifying arrhythmogenic substrates will be assessed by comparison with conventional electroanatomical mapping. Accuracy will be reported as the percentage of ECGI findings that correspond with findings from conventional electroanatomical mapping.
SecondaryPercentage of procedures with successful mapping completed12 MonthsPercentage of procedures with successful mapping completed will be determined by the findings that correspond with findings from conventional electroanatomical mapping.
OtherNumber of Participants With Atrial Fibrillation Termination to Sinus RhythmBaselineNumber of participants with atrial fibrillation during the index catheter ablation procedure whose rhythm terminates to sinus rhythm during the procedure.
OtherNumber of Participants With Atrial Fibrillation Conversion to Atrial FlutterBaselineNumber of participants with atrial fibrillation during the index catheter ablation procedure whose rhythm converts to atrial flutter during the procedure.
OtherRadiation Exposure TimeBaselineDuration of radiation exposure during the index catheter ablation procedure, reported in minutes.
OtherTotal duration of index catheter ablation procedureBaselineTotal duration of the index catheter ablation procedure measured in minutes

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07904377

GET https://conductscience.org/api/trials/v1/NCT07904377/registered